Special Issue "Emerging Trends in Inhaled Drug Delivery"
Deadline for manuscript submissions: 28 May 2024 | Viewed by 73
Interests: inhaled drug delivery; thermostable vaccines; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Inhaled drug delivery is an excellent choice for non-invasive administration of drugs and has gained significant attention in the past decade or so. Pulmonary delivery allows for the direct administration of drugs/ biologics into the lungs for the treatment of both local and systemic diseases. The lungs, as a delivery site, offer many advantages such as a large surface area, dense vasculature, lower enzymatic activity than the gut, and a thin alveolar epithelium that allows for rapid absorption and immediate onset of action. The right combination of formulation and device is needed to generate particles or droplets of an appropriate aerodynamic diameter to achieve deposition in the respiratory airways. Recent advances in the field of pharmaceutical engineering, quality-by-design, and process analytical technology have enabled significant progress in formulation development for inhaled delivery.
In this Special Issue, we aim to collect articles that highlight and discuss the latest advances and emerging trends in inhaled drug delivery. Potential articles for this Special Issue may focus on the role of nanoparticles in pulmonary drug delivery, a quality-by-design-based approach toward the development of inhalable formulations, repurposing and reformulation of drugs and drug products for inhaled delivery, targeted delivery to specific regions of the lungs, and pulmonary vaccine delivery.
Dr. Nitesh K. Kunda
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- inhaled drug delivery
- nanoparticles in inhalation
- pulmonary vaccine delivery